CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dominey, A. M.
Right arrow Articles by Greenhalgh, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dominey, A. M.
Right arrow Articles by Greenhalgh, D. A.

Cell Growth & Differentiation, Vol 4, Issue 12 1071-1082, Copyright © 1993 by American Association of Cancer Research

ARTICLES

Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas

AM Dominey, XJ Wang, LE King Jr, LB Nanney, TA Gagne, K Sellheyer, DS Bundman, MA Longley, JA Rothnagel and DA Greenhalgh
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.

To assess the effects of transforming growth factor alpha (TGF-alpha) on mammalian skin in vivo, we have targeted its expression to the epidermis of transgenic mice using a vector based on the human K1 (HK1) gene. Neonatal mice expressing the HK1.TGF-alpha transgene were often smaller than normal littermates and had precocious eyelid opening and wrinkled, scaly skin with diffuse alopecia. Juvenile transgenic mouse epidermis was uniformly hyperkeratotic, but this pattern was generally less pronounced in adult transgenic mice unless they expressed high levels of the HK1.TGF-alpha transgene. Spontaneous, squamous papillomas occurred at sites of wounding in adult mice expressing high levels of HK1.TGF-alpha; however, most were prone to regression. Immunoreactive TGF-alpha was 2-6 times higher in the epidermis of these HK1.TGF-alpha lines. Immunoreactive epidermal growth factor receptor had a normal pattern of expression in nonphenotypic adult epidermis, but a marked reduction in the receptor population was detected in hyperplastic newborn epidermis and phenotypic adult epidermis. Autoradiographic localization of 125I-epidermal growth factor showed a similar pattern of distribution, suggesting that the sites of increased TGF-alpha expression induced epidermal growth factor receptor down-regulation. These data demonstrate the in vivo effect of deregulated TGF-alpha expression on epidermal proliferation and differentiation and suggest a potential role for TGF-alpha in carcinogenesis and other hyperproliferative epidermal disorders.


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
M. R. Schneider, S. Werner, R. Paus, and E. Wolf
Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology
Am. J. Pathol., July 1, 2008; 173(1): 14 - 24.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Honda, T. Sakaguchi, K. Sakai, C. Schmedt, A. Ramirez, J. L. Jorcano, A. Tarakhovsky, H. Kamisoyama, and T. Sakai
Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk
Carcinogenesis, October 1, 2007; 28(10): 2074 - 2081.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. T. Charalambous, A. Hannigan, P. Tsimbouri, G. M. McPhee, and J. B. Wilson
Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia
Carcinogenesis, August 1, 2007; 28(8): 1839 - 1848.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. P. Maufort, S. M. Genther Williams, H. C. Pitot, and P. F. Lambert
Human Papillomavirus 16 E5 Oncogene Contributes to Two Stages of Skin Carcinogenesis
Cancer Res., July 1, 2007; 67(13): 6106 - 6112.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
X. Wang, D. Bolotin, D. H. Chu, L. Polak, T. Williams, and E. Fuchs
AP-2{alpha}: a regulator of EGF receptor signaling and proliferation in skin epidermis
J. Cell Biol., January 30, 2006; 172(3): 409 - 421.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Stevenson, C. Charalambous, and J. B. Wilson
Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGF{alpha} Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9
Cancer Res., October 1, 2005; 65(19): 8826 - 8835.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Genther Williams, G. L. Disbrow, R. Schlegel, D. Lee, D. W. Threadgill, and P. F. Lambert
Requirement of Epidermal Growth Factor Receptor for Hyperplasia Induced by E5, a High-Risk Human Papillomavirus Oncogene
Cancer Res., August 1, 2005; 65(15): 6534 - 6542.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. J. Feith, D. K. Bol, J. M. Carboni, M. J. Lynch, S. Sass-Kuhn, P. L. Shoop, and L. M. Shantz
Induction of Ornithine Decarboxylase Activity Is a Necessary Step for Mitogen-Activated Protein Kinase Kinase-Induced Skin Tumorigenesis
Cancer Res., January 15, 2005; 65(2): 572 - 578.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Cancer Res., April 1, 2004; 64(7): 2382 - 2389.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Nunes, C. Shi, and L. M. Greenberger
Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes
Mol. Cancer Ther., January 1, 2004; 3(1): 21 - 27.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
E. K. Griffiths, O. Sanchez, P. Mill, C. Krawczyk, C. V. Hojilla, E. Rubin, M. M. Nau, R. Khokha, S. Lipkowitz, C.-c. Hui, et al.
Cbl-3-Deficient Mice Exhibit Normal Epithelial Development
Mol. Cell. Biol., November 1, 2003; 23(21): 7708 - 7718.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Mascia, V. Mariani, G. Girolomoni, and S. Pastore
Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation
Am. J. Pathol., July 1, 2003; 163(1): 303 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Suzuki, S. Itami, M. Ohishi, K. Hamada, T. Inoue, N. Komazawa, H. Senoo, T. Sasaki, J. Takeda, M. Manabe, et al.
Keratinocyte-specific Pten Deficiency Results in Epidermal Hyperplasia, Accelerated Hair Follicle Morphogenesis and Tumor Formation
Cancer Res., February 1, 2003; 63(3): 674 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Curran, F. S. Laverty, D. Campbell, J. Macdiarmid, and J. B. Wilson
Epstein-Barr Virus Encoded Latent Membrane Protein-1 Induces Epithelial Cell Proliferation and Sensitizes Transgenic Mice to Chemical Carcinogenesis
Cancer Res., September 1, 2001; 61(18): 6730 - 6738.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
Y. Suga, M. Jarnik, P. S. Attar, M. A. Longley, D. Bundman, A. C. Steven, P. J. Koch, and D. R. Roop
Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
J. Cell Biol., October 18, 2000; 151(2): 401 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Lahiri-Chatterjee, S. K. Katiyar, R. R. Mohan, and R. Agarwal
A Flavonoid Antioxidant, Silymarin, Affords Exceptionally High Protection against Tumor Promotion in the SENCAR Mouse Skin Tumorigenesis Model
Cancer Res., February 1, 1999; 59(3): 622 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. R. Germolec, J. Spalding, H.-S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida, et al.
Arsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors
Am. J. Pathol., December 1, 1998; 153(6): 1775 - 1785.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X.-J. Wang, D. A. Greenhalgh, J. R. Bickenbach, A. Jiang, D. S. Bundman, T. Krieg, R. Derynck, and D. R. Roop
Expression of a dominant-negative type II transforming growth factor beta  (TGF-beta ) receptor in the epidermis of transgenic mice blocks TGF-beta -mediated growth inhibition
PNAS, March 18, 1997; 94(6): 2386 - 2391.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. J. McCawley, P. O'Brien, and L. G. Hudson
Overexpression of the Epidermal Growth Factor Receptor Contributes to Enhanced Ligand-Mediated Motility in Keratinocyte Cell Lines
Endocrinology, January 1, 1997; 138(1): 121 - 127.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M Sibilia and E. Wagner
Strain-dependent epithelial defects in mice lacking the EGF receptor
Science, July 14, 1995; 269(5221): 234 - 238.
[Abstract] [PDF]

Home page
 Genes Dev.Home page
S Imakado, J R Bickenbach, D S Bundman, J A Rothnagel, P S Attar, X J Wang, V R Walczak, S Wisniewski, J Pote, and J S Gordon
Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function.
Genes & Dev., February 1, 1995; 9(3): 317 - 329.
[Abstract] [PDF]

Home page
 ScienceHome page
D Roop
Defects in the barrier
Science, January 27, 1995; 267(5197): 474 - 475.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.